Inicio

Eltrombopag

Eltrombopag

Especificaciones

496775-61-2Número CAS
3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acidNombre IUPAC
C25H22N4O4Fórmula química
442.5 g/molPeso molecular
Eltrombopag; 496775-61-2; Eltrombopag [INN]; (Z)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; SB497115; Eltrombopag-Isomer; 376591-99-0; SB 497115; 1807882-48-9; (E)-Eltrombopag; (ZE)-Eltrombopag; 3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; DTXSID5057753; SB-497115; MFCD20926253; CHEMBL461101; S56D65XJ9G; 3'-{2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazin-1-yl}-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; C25H22N4O4; 3'-[(2Z)-2-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy[1,1'-biphenyl]-3-carboxylic acid; 3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid; NCGC00274067-01; UNII-S56D65XJ9G; (E)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; (Z)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazineyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; 3'-{2-[(4E)-1-(3,4-dimethylphenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazin-1-yl}-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; Eltrombopag free base; HSDB 8212; 496775-61-2 (free base); Eltrombopag (Standard); ELTROMBOPAG [MI]; (E/Z)-Eltrombopag 13C; ELTROMBOPAG [VANDF]; ELTROMBOPAG [MART.]; SCHEMBL18910; ELTROMBOPAG [WHO-DD]; (Z)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,; 3'-[[1-(3,4-DiMethylphenyl)-1,5-dihydro-3-Methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; MLS006010024; SCHEMBL164270; SCHEMBL211081; SCHEMBL211082; Eltrombopag (SB-497115); ELTROMBOPAG [EMA EPAR]; AMG531; CHEMBL478463; GTPL6961; orb1224942; orb1305316; CHEMBL3186485; DTXCID6031542; Eltrombopag - Bio-X trade mark; SCHEMBL26684256; SCHEMBL29385318; SCHEMBL29386056; SCHEMBL29386140; SCHEMBL29405370; SCHEMBL30966490; CHEBI:85010; EX-A443; XDXWLKQMMKQXPV-QYQHSDTDSA-N; XDXWLKQMMKQXPV-UHFFFAOYSA-N; Eltrombopag (SB-497115-GR); GLXC-90394; HMS3655B14; HMS3743O17; HMS3751E19; HMS5083K21; SYB23031; Eltrombopag (SB-497115-GR)?; Tox21_113965; BDBM50248106; EBC-13607; EBC-13810; HY-15306R; MFCD21090400; s4502; AKOS015920246; AKOS026750537; AKOS030524935; AKOS037515498; CCG-269152; DB06210; EX-7216; FE22658; SB19101; NCGC00274067-02; NCGC00274067-05; NCGC00274067-07; 3'-(2-(2-(3,4-DIMETHYLPHENYL)-5-METHYL-3-OXO-2,3-DIHYDRO-1H-PYRAZOL-4-YL)HYDRAZONO)-2'-OXO-2',3'-DIHYDRO-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID; 3'-{2-[(4Z)-1-(3,4-dimethylphenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazin-1-yl}-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; 3-[(5E)-5-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]hydrazono]-6-oxo-cyclohexa-1,3-dien-1-yl]benzoic acid; AS-19180; AS-35176; BE164406; HY-15306; SMR004701208; SY108591; CAS-496775-61-2; NS00031938; SB-497 115; SW219608-1; T2562; SB-497115-GR;SB497115; C75316; EN300-260743; AB01274808-01; AB01274808_02; EN300-1709152; Eltrombopag Impurity 46(Mixture Of Z/E-Isomers); EN300-23586760; Q411588; BRD-K40496271-001-02-5; BRD-K40496271-001-03-3; BRD-K40496271-396-01-1; Z2568748600; (1,1'-Biphenyl)-3-carboxylic acid, 3'-((2Z)-(1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene)hydrazino)-2'-hydroxy-; (Z)-3 inverted exclamation mark -[2-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxopyrazol-4(5H)-ylidene]hydrazino]-2 inverted exclamation mark -oxo-2 inverted exclamation mark ,3 inverted exclamation mark -dihydrobiphenyl-3-carboxylic Acid; (Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxybiphenyl-3-carboxylic acid; [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-; [1,1'-Biphenyl]-3-carboxylic acid, 3'-[2-[1-(3,4-dimethylphenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]diazenyl]-2'-hydroxy-; 3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazineyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; 3'-[(2Z)- [1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; 3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxyl ic acid; 3'-{(2E)-2-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]hydrazin-1-yl}-2'-hydroxy[1,1'-biphenyl]-3-carboxylic acid; 3'-{(2z)-2-(1-[3,4-dimethylphenyl]-3-methyl-5-oxo-1,5-dihydro-4h-pyrazol-4-ylidene)diazanyl}-2'-hydroxybiphenyl-3-carboxylic acid; 3'-{(2Z)-2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; 3'-{(2Z)-2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]hydrazinyl}-2'-hydroxy[1,1'-biphenyl]-3-carboxylic acid; 3'-{N'-[1-(3,4-dimethyl-phenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-pyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; 3-(3-{2-[(4Z)-1-(3,4-dimethylphenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazin-1-yl}-2-hydroxyphenyl)benzoic acid; 3-[(5E)-5-{2-[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-2,3-dihydro-1H-pyrazol-4-yl]hydrazin-1-ylidene}-6-oxocyclohexa-1,3-dien-1-yl]benzoic acid; 3-[(5Z)-5-{2-[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-2,3-dihydro-1H-pyrazol-4-yl]hydrazin-1-ylidene}-6-oxocyclohexa-1,3-dien-1-yl]benzoic acid; 3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]azo]-2-hydroxy-phenyl]benzoic acidSinónimos